Physician profile
Terry Copperman
NPI 1326065251
$432.88
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.14 · 2020: $71.26 · 2021: $249 · 2022: $44.74 · 2023: $48.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $97.44 | 2020-2022 | |
| Boston Scientific Corporation | $55.81 | 2021 | |
| Lilly USA, LLC | $54.36 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.77 | 2021 | |
| Abbvie INC. | $46.04 | 2021-2023 | Viberzi, Linzess |
| Amgen INC. | $24.01 | 2021 | |
| Amarin Pharma, INC. | $23.50 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.18 | 2022 | |
| Mylan Specialty L.P. | $21.58 | 2023 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $14.14 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Copperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.